DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

NATIXIS's Holding History (CIK: 0001274981)

Note: Option positions (PUT/CALL) are excluded.

Q3 2022

Shares 69,030 Value ($000) $2,119 Avg Close $32.51 Range $25.88 - $39.43

Q2 2022

Shares 69,030 Value ($000) $2,032 Avg Close $26.20 Range $20.24 - $35.62

Q1 2022

Shares 236,688 Value ($000) $7,614 Avg Close $34.41 Range $28.76 - $47.47

Q4 2021

Shares 293,554 Value ($000) $13,093 Avg Close $47.38 Range $41.10 - $56.08

Q3 2021

Shares 279,254 Value ($000) $14,088 Avg Close $56.36 Range $47.02 - $79.50

Q2 2021

Shares 209,698 Value ($000) $16,449 Avg Close $61.86 Range $49.20 - $79.70

Q1 2021

Shares 139,698 Value ($000) $7,977 Avg Close $66.94 Range $52.23 - $84.25

Q4 2020

Shares 290,698 Value ($000) $24,349 Avg Close $60.45 Range $35.89 - $93.94

Q3 2020

Shares 25,988 Value ($000) $931 Avg Close $30.12 Range $22.36 - $39.22

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2022	69,030	$2,119	$32.51	$25.88 - $39.43
Q2 2022	69,030	$2,032	$26.20	$20.24 - $35.62
Q1 2022	236,688	$7,614	$34.41	$28.76 - $47.47
Q4 2021	293,554	$13,093	$47.38	$41.10 - $56.08
Q3 2021	279,254	$14,088	$56.36	$47.02 - $79.50
Q2 2021	209,698	$16,449	$61.86	$49.20 - $79.70
Q1 2021	139,698	$7,977	$66.94	$52.23 - $84.25
Q4 2020	290,698	$24,349	$60.45	$35.89 - $93.94
Q3 2020	25,988	$931	$30.12	$22.36 - $39.22